Dr Marta Di Forti: key facts
- Kind of voice
- Academic
- Role
- Professor of Drug Use, Genetics and Psychosis
- Organisation based in
- Peckham
- Quoted on
- Hospital discharge / bed-blocking
- Tracked press citations
- 1
- Most recently quoted
- 27 Aug 2026
Who Dr Marta Di Forti is
Professor Marta Di Forti is Professor of Drug Use, Genetics and Psychosis at the Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London. She is also an Honorary Consultant Adult Psychiatrist at the Lambeth Early Intervention Community team, South London and Maudsley NHS Foundation Trust. She leads the UK's first Cannabis Clinic for patients with psychosis at South London and Maudsley NHS Foundation Trust, and established Europe's first dedicated clinic for young people with cannabis-induced psychosis. She is the first author of three of the five most frequently cited research papers on cannabis use and psychosis, and her EU-GEI study ranked among the world's most influential scientific studies of 2019 in the Altmetric Top 100. Her research and public commentary argue that high-potency cannabis use is an independent and preventable risk factor for psychotic disorders, a position cited by the US Surgeon General and referenced in the UK and European Parliaments.
“Of course, it is a huge wasted opportunity. The chances of them getting a severe presentation of their psychosis and needing hospital admission is between three and four times greater.”
References for this biography
- 1.Professor Marta Di Forti delivers Inaugural Lecture | King's College London — Confirms current role title, IoPPN affiliation, Cannabis Clinic leadership, European first clinic, and SIRS 2025 award
- 2.Professor Marta Di Forti MD, MRCPsych, PhD | King's College London — Official KCL staff page confirming role, organisation, Cannabis Clinic leadership, and MRC Fellowship
- 3.2025 Outstanding Translational Research Award | Schizophrenia International Research Society — Confirms RCPsych prizes (2021, 2023), EU-GEI impact, public and parliamentary influence of her work, and European clinic
- 4.Dr Marta Di Forti awarded MRC Senior Clinical Fellowship | King's College London — Confirms MRC Senior Research Fellowship award in 2020 and Altmetric Top 100 ranking of EU-GEI paper
- 5.Marta Di Forti – King's College London research portal — Confirms ORCID identifier and role title
- 6.Marta Di Forti (@MartaDiForti) on X — Confirms verified X/Twitter account with self-identified role description matching KCL records
Notable achievements
- Awarded the Schizophrenia International Research Society Outstanding Translational Research Award 2025 Source ↗
- Awarded the Royal College of Psychiatrists Prize for Academic Psychiatrist of the Year 2023 Source ↗
- Awarded the Royal College of Psychiatrists Researcher of the Year prize (2021) Source ↗
- Granted MRC Senior Research Fellowship (2020) worth over £2.5 million to expand research into cannabis use, psychosis and its underlying biology Source ↗
- EU-GEI paper on cannabis use variation and psychosis incidence ranked in Altmetric Top 100 most influential scientific studies globally in 2019 Source ↗
- Established the UK's first Cannabis Clinic for patients with psychotic disorders at South London and Maudsley NHS Foundation Trust Source ↗
- Established Europe's first dedicated clinic for young people with cannabis-induced psychosis Source ↗
Where Dr Marta Di Forti has been quoted
- ‘I’d run down the road thinking I was God’: a day at the cannabis psychosis clinictheguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Contact & links
- Staff pagehttps://www.kcl.ac.uk/people/marta-di-forti
- ORCIDhttps://orcid.org/0000-0002-3218-6925published here ↗
- Xhttps://x.com/MartaDiFortipublished here ↗
Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.